Evidence map›Paper›PMID 27852055›Full record

ArticleOncotarget2017

Isochaihulactone-induced DDIT3 causes ER stress-PERK independent apoptosis in glioblastoma multiforme cells.

Sheng-Feng Tsai, Michael Tao, Li-Ing Ho, Tzyy-Wen Chiou, Shinn-Zong Lin, Hong-Lin Su, Horng-Jyh Harn

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The Molecular Mechanisms of Plant-Derived Compounds Targeting Brain Cancer.International journal of molecular sciences · 2018
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Sheng-Feng TsaiDepartment of Life Sciences, National Chung-Hsing University, Taichung, Taiwan.
Michael TaoDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA.
Li-Ing HoDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Tzyy-Wen ChiouDepartment of Life Science, Graduate Institute of Biotechnology, National Dong Hwa University, Hualien, Taiwan.
Shinn-Zong LinBioinnovation Center, Tzu Chi foundation, Department of Neurosurgery, Hualien Tzu Chi Hospital, Hualien, Taiwan.
Hong-Lin SuDepartment of Life Sciences, National Chung-Hsing University, Taichung, Taiwan.
Horng-Jyh HarnBioinnovation Center, Tzu Chi Foundation, Department of Pathology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.
National Chung Hsing University · TWChina Medical University · TWNational Dong Hwa University · TWNational Yang Ming Chiao Tung University · TWTzu Chi Foundation · TWUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endoplasmic reticulum (ER) is a major site of cellular homeostasis regulation. Under the ER stress condition, Glioblastoma multiform (GBM) cells activate the unfolded protein response. In this study, we discovered isochaihulactone, a natural compound extracted from the Chinese traditional herb Nan-Chai-Hu, which can disrupt ER homeostasis in GBM cell lines. It can induce DNA damage inducible transcript 3 (DDIT3) expression which is independent of 78 kDa glucose-regulated protein (GRP78) and protein kinase RNA-like endoplasmic reticulum kinase (PERK) expression. Flow cytometry results revealed that isochaihulactone trigger the cell cycle arrest at G2/M phase and apoptosis in GBM cells. Isochaihulactone induced DDIT3 led to the expression of NAG-1. The in vivo study showed that isochaihulactone suppressed tumor growth, and DDIT3 and Caspase3 overexpressed in the xenograft model, which is consistent with the in vitro study. Overall, the data revealed that isochaihulactone disrupted ER homeostasis in cancer cells by increasing DDIT3 and NAG-1 expression. Our finding also provides a therapeutic strategy by using isochaihulactone for GBM treatment.

Indexed as

4-ButyrolactoneAnimalsAntineoplastic Agents, PhytogenicBenzodioxolesCaspase 3Cell CycleCell Line, TumorCell SurvivaleIF-2 KinaseEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressGene Expression Regulation, NeoplasticGlioblastomaGrowth Differentiation Factor 15HumansMice4-ButyrolactoneAntineoplastic Agents, PhytogenicBenzodioxolesCASP3 protein, humanCaspase 3DDIT3 protein, humanEIF2AK3 protein, humaneIF-2 KinaseEndoplasmic Reticulum Chaperone BiPGDF15 protein, humanGrowth Differentiation Factor 15HSPA5 protein, humanHspa5 protein, mouseisochaihulactoneTranscription Factor CHOPDDIT3ER stressglioblastomaisochaihulactoneNAG-1

Identifiers

PMID27852055
PMCPMC5354812
OpenAlexW2555044057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.